查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855954

2025年全球照护现场血脂检测市场报告

Point Of Care Lipid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，照护现场，预计将从2024年的6.8亿美元成长到2025年的7.4亿美元，复合年增长率达9.9%。这段历史性成长时期主要受以下因素驱动：心血管疾病和血脂异常症盛行率上升、多参数和多重检测技术的普及、医疗保健支出和报销支持的增加、人们对预防保健的认识和重视程度不断提高，以及零售药局、诊所和社区的广泛应用。

预计未来几年，照护现场血脂检测市场将维持强劲成长，2029年市场规模将达到10.7亿美元，复合年增长率（CAGR）为9.5%。预测期内的成长主要受以下因素驱动：家庭和自我监测场景下检测技术的普及、人们对遗传性血脂异常症的认识和筛检不断提高、慢性病负担日益加重、医疗模式转变为价值导向模式以及耗材需求稳定。预测期内的关键趋势包括：行动科技的进步、与数位健康系统的整合、远端患者监护和远端医疗平台的应用、物联网医疗（IoMT）和连线健诊的整合，以及边缘运算和低功耗生物感测器晶片的发展。

照护现场血脂检测是一种快速诊断检测，无需将样本送往中心实验室，即可透过指尖血液样本测量胆固醇和三酸甘油酯水平，从而提供快速结果，以支持心血管风险评估和持续监测。

主要产品类型包括仪器、耗材及其他。仪器包括携带式分析仪和检测设备，旨在为患者在护理点或附近快速评估血脂谱，例如胆固醇和三酸甘油酯水平。这些解决方案适用于高血脂症、高三酸甘油脂血症、唐吉尔氏症、高脂蛋白血症和遗传性高胆固醇症等疾病。主要终端使用者包括医院、诊所、诊断实验室和居家医疗保健机构。

美国关税的快速上涨以及随之而来的2025年春季贸易摩擦，正对医疗设备产业产生重大影响，尤其是进口诊断影像设备零件、手术用不銹钢和塑胶耗材。医院和诊所都在抵制价格上涨，这挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）全新系列报告的一部分，提供照护现场血脂检测市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、照护现场的照护现场、市场趋势以及商机，照护现场。本照护现场照护现场检测市场研究报告对产业现状及未来发展趋势进行了深入分析，为您提供所需的全面观点。

心血管疾病盛行率的不断上升预计将推动照护现场血脂检测市场的成长。心血管疾病包括影响心臟和血管的疾病，例如冠状动脉疾病、中风和高血压，这些疾病通常由动脉粥状硬化引起，而动脉粥状硬化又与胆固醇和三酸甘油酯水平异常有关。心血管疾病发生率的上升主要是由于久坐不动的生活方式和体力活动减少，这会导致肥胖、血液循环不良和其他危险因子。即时血脂检测在应对这一趋势中发挥关键作用，它可以快速现场测量胆固醇和血脂水平，从而实现早期风险检测和及时干预，防止併发症的发生。例如，美国心臟协会报告称，2024年1月，心血管疾病死亡人数为931,578人，比前一年增加了3,000人。心血管疾病负担的加重正在推动对照护现场血脂检测的需求。

即时血脂检测市场的主要企业正致力于开发先进的诊断平台，以改善临床决策和病患管理。这些平台是可携式整合设备，可在患者床边快速进行实验室级的血脂检查，从而实现即时决策和即时治疗。例如，2023年7月，总部位于加拿大的健康科技公司Vital Biosciences推出了其VitalOne平台。这款可携式设备可在诊所和药房等场所，仅需20分钟即可提供超过50种血液检测的实验室级结果。该平台将血液学、临床化学和免疫检测整合于一台仪器中，使医护人员能够在一次就诊中完成检测、诊断和治疗。这项技术创新提高了患者照护的可及性、速度和个人化程度，同时保持了与传统临床检测相当的准确性。

2023年5月，美国即时检测设备製造商PTS Diagnostics与法国BIOSYNEX SA公司达成合作，旨在提升全球慢性疾病患者的医疗服务水准。此次合作旨在拓展即时血脂和糖化血红蛋白（A1C）检测服务，并改善全球心血管疾病和糖尿病的诊疗水平。 BIOSYNEX总部位于法国，专注于快速诊断检测产品的研发和销售，其中包括照护现场血脂检测解决方案。

照护现场血脂检测市场由血脂检测、诊断支援服务、居家检测服务和技术支援服务等服务提供者所获得的收入所构成。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。照护现场血脂检测市场涵盖试纸、血脂分析仪、手持式血脂检测设备、胆固醇检测设备、多参数检测设备、采血针、品控液、试剂组、无线血脂检测设备和蓝牙血脂监测仪的销售。这代表了产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向终端客户销售的产品价值。该市场的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球照护现场血脂检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球照护现场血脂检测市场：成长率分析
  • 全球照护现场血脂检测市场表现：规模与成长，2019-2024年
  • 全球照护现场血脂检测市场预测：规模与成长，2024-2029年，2034年预测
  • 全球照护现场血脂检测：潜在市场规模 (TAM)

第六章 市场细分

  • 全球照护现场，2019-2024年、2024-2029年预测、2034年预测
  • 测量设备
  • 消耗品
  • 其他产品类型
  • 全球照护现场血脂检测市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 高血脂症
  • 高三酸甘油脂血症
  • 唐吉尔氏症
  • 高脂蛋白血症
  • 遗传性高胆固醇症
  • 其他用途
  • 全球照护现场，实际数据及预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 医院
  • 诊所
  • 诊断实验室
  • 家庭护理机构
  • 其他最终用户
  • 全球照护现场血脂检测市场：按设备、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 桌上型分析仪
  • 可携式或手持式分析仪
  • 多参数分析仪
  • 单参数分析仪
  • 全球照护现场血脂检测市场：按耗材、类型、实际值和预测值分類的细分市场，2019-2024年、2024-2029年预测值、2034年预测值
  • 试纸
  • 试剂和套件
  • 品管材料
  • 校准器
  • 全球照护现场血脂检测市场：依产品类型细分，依类型划分，实际值及预测值（2019-2024年、2024-2029年预测值、2034年预测值）。
  • 软体解决方案
  • 配件
  • 资料管理和连接工具

第七章 区域和国家分析

  • 全球照护现场血脂检测市场：区域分析、预测及趋势（2019-2024年、2024-2029年预测、2034年预测）
  • 全球照护现场血脂检测市场：国家、市场表现及预测，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 照护现场血脂检测市场：竞争格局
  • 照护现场血脂检测市场：公司概况
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Bio-Rad Laboratories Inc.
  • Horiba ABX SAS
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Fisher Scientific International Inc.
  • Everlywell Inc.
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • VivaChek Biotech（Hangzhou）Co. Ltd.
  • EuroMedix International NV
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AccuBioTech Co. Ltd.
  • Callegari Srl
  • MiCo BioMed Co. Ltd.
  • BHR Diagnostics Private Limited

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年照护现场血脂检测市场：提供新机会的国家
  • 2029年照护现场血脂检测市场：充满新机会的细分市场
  • 照护现场血脂检测市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38606

A point of care lipid test is a rapid diagnostic test that uses a fingerstick blood sample to measure cholesterol and triglyceride levels without sending samples to a central laboratory. It provides fast results to support cardiovascular risk assessment and ongoing monitoring.

The primary product types of point of care lipid tests are instruments, consumables, and others. Instruments include portable analyzers and testing devices designed to quickly assess lipid profiles, such as cholesterol and triglyceride levels, at or near the patient care site. These solutions are applied in conditions such as hyperlipidemia, hypertriglyceridemia, Tangier disease, hyperlipoproteinemia, familial hypercholesterolemia, and others. Key end users include hospitals, clinics, diagnostic laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point of care lipid test market research report is one of a series of new reports from The Business Research Company that provides point of care lipid test market statistics, including the point of care lipid test industry global market size, regional shares, competitors with the point of care lipid test market share, detailed point of care lipid test market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care lipid test industry. This point of care lipid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point of care lipid test market size has grown strongly in recent years. It will grow from $0.68 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period was driven by the rising prevalence of cardiovascular disease and dyslipidemia, expansion of multi-analyte and multiplex testing, increasing healthcare expenditure and reimbursement support, growing awareness and focus on preventive healthcare, and wider adoption in retail pharmacies, clinics, and community settings.

The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period is fueled by increasing adoption in home based and self-monitoring settings, rising awareness and screening for genetic lipid disorders, growing chronic disease burden, the shift toward value based healthcare models, and stable demand for consumables. The primary trends in the forecast period include advancements in portable technology, integration with digital health systems, incorporation into remote patient monitoring and telemedicine platforms, integration within IoMT or connected health infrastructure, and development of edge computing and low-power biosensor chips.

The growing prevalence of cardiovascular diseases is expected to drive the growth of the point-of-care lipid test market. Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as coronary artery disease, stroke, and hypertension, often resulting from atherosclerosis linked to abnormal cholesterol and triglyceride levels. The rise in cardiovascular diseases is largely due to sedentary lifestyles and decreased physical activity, leading to obesity, poor circulation, and other risk factors. Point-of-care lipid tests play a crucial role in managing this trend by offering rapid, on-site measurement of cholesterol and lipid levels, enabling early identification of risk and timely intervention to prevent further complications. For example, the American Heart Association reported in January 2024 that cardiovascular diseases caused 931,578 deaths, a rise of 3,000 compared to the previous year. This increasing burden of cardiovascular diseases is driving the demand for point-of-care lipid tests.

Leading companies in the point-of-care lipid test market are focusing on advanced diagnostic platforms to improve clinical decision-making and patient management. These platforms are portable, integrated devices capable of performing rapid, lab-quality lipid panel tests at the patient's bedside, allowing real-time decision-making and immediate treatment. For example, in July 2023, Vital Biosciences Inc., a health tech company based in Canada, introduced the VitalOne platform. This portable device delivers over 50 lab-grade blood test results in just 20 minutes at locations such as clinics and pharmacies. The platform combines hematology, clinical chemistry, and immunoassays in one device, enabling healthcare providers to perform testing, diagnosis, and treatment during a single visit. This innovation improves access, speed, and personalization of patient care, while maintaining accuracy comparable to traditional laboratory tests.

In May 2023, PTS Diagnostics, a US-based manufacturer of point-of-care testing devices, partnered with BIOSYNEX S.A. to enhance care for patients with chronic diseases worldwide. The collaboration aims to expand their point-of-care lipid and A1C testing services, improving cardiovascular and diabetes care on a global scale. BIOSYNEX, based in France, specializes in developing and distributing rapid diagnostic tests, including point-of-care lipid testing solutions.

Major players in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.

North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care lipid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care lipid test market consists of revenues earned by entities by providing services such as lipid profile testing services, diagnostic support services, home-based testing services, and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care lipid test market includes the sale of test strips, lipid panel analyzers, handheld lipid testing devices, cholesterol testing devices, multi-parameter testing devices, lancets, control solutions, reagent kits, wireless lipid testing devices, and Bluetooth-enabled lipid monitors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Lipid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care lipid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care lipid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care lipid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Types: Instruments; Consumables; Other Product Types
  • 2) By Application: Hyperlipidemia; Hypertriglyceridemia; Tangier Disease; Hyperlipoproteinemia; Familial Hypercholesterolemia; Other Applications
  • 3) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Analyzers; Portable Or Handheld Analyzers; Multi-parameter Analyzers; Single-parameter Analyzers
  • 2) By Consumables: Test Strips; Reagents And Kits; Quality Control Materials; Calibrators
  • 3) By Other Product Types: Software Solutions; Accessories; Data Management And Connectivity Tools
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Becton Dickinson and Company; Quidel Corporation; Bio-Rad Laboratories Inc.; Horiba ABX SAS; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; Fisher Scientific International Inc.; Everlywell Inc.; EKF Diagnostics Holdings plc; Trinity Biotech plc; VivaChek Biotech (Hangzhou) Co. Ltd.; EuroMedix International NV; A. Menarini Industrie Farmaceutiche Riunite S.r.l.; AccuBioTech Co. Ltd.; Callegari S.r.l.; MiCo BioMed Co. Ltd.; BHR Diagnostics Private Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Lipid Test Market Characteristics

3. Point Of Care Lipid Test Market Trends And Strategies

4. Point Of Care Lipid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Lipid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point Of Care Lipid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point Of Care Lipid Test Market Growth Rate Analysis
  • 5.4. Global Point Of Care Lipid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point Of Care Lipid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point Of Care Lipid Test Total Addressable Market (TAM)

6. Point Of Care Lipid Test Market Segmentation

  • 6.1. Global Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Other Product Types
  • 6.2. Global Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Tangier Disease
  • Hyperlipoproteinemia
  • Familial Hypercholesterolemia
  • Other Applications
  • 6.3. Global Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.4. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benchtop Analyzers
  • Portable Or Handheld Analyzers
  • Multi-parameter Analyzers
  • Single-parameter Analyzers
  • 6.5. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Strips
  • Reagents And Kits
  • Quality Control Materials
  • Calibrators
  • 6.6. Global Point Of Care Lipid Test Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Accessories
  • Data Management And Connectivity Tools

7. Point Of Care Lipid Test Market Regional And Country Analysis

  • 7.1. Global Point Of Care Lipid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point Of Care Lipid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Lipid Test Market

  • 8.1. Asia-Pacific Point Of Care Lipid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Lipid Test Market

  • 9.1. China Point Of Care Lipid Test Market Overview
  • 9.2. China Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Lipid Test Market

  • 10.1. India Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Lipid Test Market

  • 11.1. Japan Point Of Care Lipid Test Market Overview
  • 11.2. Japan Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Lipid Test Market

  • 12.1. Australia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Lipid Test Market

  • 13.1. Indonesia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Lipid Test Market

  • 14.1. South Korea Point Of Care Lipid Test Market Overview
  • 14.2. South Korea Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Lipid Test Market

  • 15.1. Western Europe Point Of Care Lipid Test Market Overview
  • 15.2. Western Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Lipid Test Market

  • 16.1. UK Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Lipid Test Market

  • 17.1. Germany Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Lipid Test Market

  • 18.1. France Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Lipid Test Market

  • 19.1. Italy Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Lipid Test Market

  • 20.1. Spain Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Lipid Test Market

  • 21.1. Eastern Europe Point Of Care Lipid Test Market Overview
  • 21.2. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Lipid Test Market

  • 22.1. Russia Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Lipid Test Market

  • 23.1. North America Point Of Care Lipid Test Market Overview
  • 23.2. North America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Lipid Test Market

  • 24.1. USA Point Of Care Lipid Test Market Overview
  • 24.2. USA Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Lipid Test Market

  • 25.1. Canada Point Of Care Lipid Test Market Overview
  • 25.2. Canada Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Lipid Test Market

  • 26.1. South America Point Of Care Lipid Test Market Overview
  • 26.2. South America Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Lipid Test Market

  • 27.1. Brazil Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Lipid Test Market

  • 28.1. Middle East Point Of Care Lipid Test Market Overview
  • 28.2. Middle East Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Lipid Test Market

  • 29.1. Africa Point Of Care Lipid Test Market Overview
  • 29.2. Africa Point Of Care Lipid Test Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point Of Care Lipid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point Of Care Lipid Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Lipid Test Market Competitive Landscape And Company Profiles

  • 30.1. Point Of Care Lipid Test Market Competitive Landscape
  • 30.2. Point Of Care Lipid Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Lipid Test Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Horiba ABX SAS
  • 31.3. Randox Laboratories Ltd.
  • 31.4. Sekisui Diagnostics LLC
  • 31.5. Fisher Scientific International Inc.
  • 31.6. Everlywell Inc.
  • 31.7. EKF Diagnostics Holdings plc
  • 31.8. Trinity Biotech plc
  • 31.9. VivaChek Biotech (Hangzhou) Co. Ltd.
  • 31.10. EuroMedix International NV
  • 31.11. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
  • 31.12. AccuBioTech Co. Ltd.
  • 31.13. Callegari S.r.l.
  • 31.14. MiCo BioMed Co. Ltd.
  • 31.15. BHR Diagnostics Private Limited

32. Global Point Of Care Lipid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Lipid Test Market

34. Recent Developments In The Point Of Care Lipid Test Market

35. Point Of Care Lipid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Point Of Care Lipid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point Of Care Lipid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point Of Care Lipid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer